Immunogenicity 12245
Sample ID
3926
Response
Negative
Tumor Type
Melanoma
Gene Symbol
DPY19L2
Transcript ID
uc010sso.1
HLA INFO
A*01:01
TCR INFO
No TCR info found!
Full length protein sequence (205 aa)
MRLKM
1
FLTPH
6
MCVMA
11
SLICS
16
RQLFG
21
WLFRR
26
VRFEK
31
VIFGI
36
LTVMS
41
IQGYA
46
NLRNQ
51
WSIIG
56
EFNNL
61
PQEEL
66
LQWIK
71
YSTTS
76
DAVFA
81
GAMPT
86
MASIK
91
LSTLH
96
PIVNH
101
PHYED
106
ADLRA
111
RTKIV
116
YSTYS
121
RKSAK
126
EVRDK
131
LLELH
136
VNYYV
141
LEEAW
146
CVVRT
151
KPGCS
156
MLEIW
161
DVEDP
166
SNAAN
171
PPLCS
176
VLLED
181
ARPYF
186
TTVFQ
191
NSVYR
196
VLKVN
201
Mutation Information
DNA mutation:
None
Peptide Range:
82 ~ 106
Mut AA position:
94 (13 in Wild Type peptide)
Alignment
Wild Type:
"AVFAGAMPTMASIKLSTLHPIVNHP
||||||||||||.||||||||||||
Mutant:
AVFAGAMPTMASVKLSTLHPIVNHP"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) DPY19L2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay